China-based Pulnovo Medical has announced the appointment of Dr Mingdong Zhang to the company's Scientific Advisory Board (SAB). Dr Zhang will provide guidance on Pulnovo Medical's clinical development and registration strategy and supporting the company's global development plan.

Pulnovo Medical is a medical device company that focuses on innovative research and development, with the mission of meeting unmet clinical needs. Since its establishment, the firm has devoted itself to creating a global OTM (From Operating Table to Market) innovation platform for the development of ground-breaking clinical therapies. Dr Zhang's cutting-edge international outlook and research expertise in the field of medical science will greatly facilitate Pulnovo Medical's development and exploration of novel technologies, and provide new insight for the expansion of Pulnovo Medical's research and development  pipeline.

Dr Zhang is an expert in medical device regulatory and corporate medical affairs with extensive medical knowledge and international regulatory affairs experience. With over  20-years industry experience, Dr Zhang  recently retired from Boston Scientific Corporation as Chief Medical Officer and Vice President of Medical Affairs and Health Economics for Asia Pacific. Before joining Boston Scientific, he served as the Global Medical Director of Johnson & Johnson's Biosense Webster and as a Medical Officer and Epidemiologist at the US Food and Drug Administration (FDA) Center for Devices.